Ethics and Policy Surrounding Patient Access to Experimental Therapy - Jonathan Kimmelman
Research Ethics and Policy Series (REPS): Alison Bateman-House, PhD, MPH, MA
Research Ethics and Policy Series (REPS): Kim Smith Whitley, MD
Novel medical treatments, innovation, hope and headlines - Catherine Joynson
CCEPA: Science and its Publics pt. 4 - Medicine, Trust, and Experimental Treatments
Research Ethics and Policy Series (REPS): Gregg Gonsalves
Medical Ethics Interview Questions | MMI & Panel | Medical School Interview Questions
Investigational Drugs & Stem Cell Treatments: Legal and Ethical Considerations of Right to Try Laws
The Intersection of Ethics and Gene Therapy with Dr. Ben Hurlbut–The Issue
Scientific, Regulatory, and Ethical Issues with Experimental Treatments and Ebola Vaccines | AER14
CARE Panel: The Ethics and Regulation of Clinical Trials for COVID-19 Treatments
Public Access to Experimental Treatments and Its Legal Limits: The Italian Case
Perspectives on Bioethical Challenges in Today’s Healthcare Industry
Bioethics: What Does it Mean for Scientists, Clinicians and Patients?
Expanded Access Webinar - A Pathway for Early Access to Amyloidosis Treatment
Right to Try Unproven Therapies with George Q. Daley, Dean of Harvard Medical School
Improving Access to Psychological Therapies: Science, Politics, Economics and Practice
Medical Ethics and Right to Try August 2018
Influences on Patient Autonomy & Decision-Making in Early Phase Cancer Clinical Trial Participation
WSCS 2015: Challenging Bioethics Issues and Public Policy
